Annual EBIT
-$177.70M$71.03M+28.56%
Summary
- Current Value
- As of today, TXG annual EBIT is -$177.70M, up +28.56% on
- Historical Performance
- TXG annual EBIT is down -236.23% over the past 3 years, and down -535.67% over the past 5 years
- All-Time High Comparison
- TXG annual EBIT is currently -891.05% below its historical high of -$17.93M set on
- 3-Year Low Comparison
- TXG annual EBIT is +28.56% above its 3-year low of -$248.73M reached on
- Sector Comparison
- TXG annual EBIT is higher than 10.15% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$177.70M | +28.6% | -236.2% | -535.7% | -891.0% | |
| Quarterly EBIT | -$32.24M | +22.3% | +19.4% | -32.8% | – | |
| TTM EBIT | -$140.82M | +21.0% | +12.4% | -54.9% | – | |
| Price | $19.29 | +21.9% | -48.9% | -87.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $610.79M | -1.3% | +24.5% | +148.4% | +759.2% | |
| Annual EPS | -$1.52 | +30.4% | -187.4% | -366.9% | -670.4% | |
| Annual EBITDA | -$133.99M | +34.7% | -444.8% | -541.5% | -883.4% | |
| Annual Net Income | -$182.63M | +28.4% | -213.7% | -484.4% | -873.4% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$161.50M | N/A | -10.0% |
| 5Y | -$52.85M | -236.2% | |
| All | -$17.93M | -891.0% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$248.73M | +28.6% | |
| 5Y | -$532.79M | N/A | +66.7% |
| All | -$532.79M | +66.7% |
EBIT History
| Year | Value | Change |
|---|---|---|
| -$177.70M | +28.6% | |
| -$248.73M | -54.0% | |
| -$161.50M | -205.6% | |
| -$52.85M | +90.1% |
| Year | Value | Change |
|---|---|---|
| -$532.79M | -1,806.0% | |
| -$27.95M | +74.6% | |
| -$109.99M | -513.4% | |
| -$17.93M | - |
FAQ
What is the current annual EBIT of TXG?
As of today, TXG annual EBIT is -$177.70M
What is 1-year change in TXG annual EBIT?
TXG annual EBIT is up +28.56% year-over-year
What is 3-year change in TXG annual EBIT?
TXG annual EBIT is down -236.23% over the past 3 years
How far is TXG annual EBIT from its all-time high?
TXG annual EBIT is currently -891.05% below its historical high of -$17.93M set on December 31, 2017
How does TXG annual EBIT rank versus sector peers?
TXG annual EBIT is higher than 10.15% of companies in Healthcare sector
When is TXG next annual earnings release?
The next annual earnings release for TXG is on
Quarterly EBIT
-$32.24M$21.67M-204.92%
Summary
- Current Value
- As of today, TXG quarterly EBIT is -$32.24M, down -204.92% on
- Historical Performance
- TXG quarterly EBIT is up +22.28% year-over-year, and up +19.39% over the past 3 years
- All-Time High Comparison
- TXG quarterly EBIT is currently -2853.37% below its historical high of $1.17M set on
- 3-Year Low Comparison
- TXG quarterly EBIT is +49.11% above its 3-year low of -$63.36M reached on
- Sector Comparison
- TXG quarterly EBIT is higher than 14.54% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$32.24M | -204.9% | +22.3% | +19.4% | -32.8% | |
| Annual EBIT | -$177.70M | – | +28.6% | -236.2% | -535.7% | |
| TTM EBIT | -$140.82M | +6.2% | +21.0% | +12.4% | -54.9% | |
| Price | $19.29 | +59.8% | +21.9% | -48.9% | -87.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $149.00M | -13.8% | -1.8% | +13.7% | +107.5% | |
| Quarterly EPS | -$0.22 | -178.9% | +26.1% | +40.4% | +66.3% | |
| Quarterly EBITDA | -$19.99M | -2065.9% | +35.0% | +37.3% | -3.0% | |
| Quarterly Net Income | -$27.47M | -179.5% | +23.2% | +34.5% | +58.3% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$10.57M | -204.9% | |
| 3Y | -$10.57M | -204.9% | |
| 5Y | -$2.36M | N/A | -1267.9% |
| All | $1.17M | -2853.4% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$49.58M | N/A | +35.0% |
| 3Y | -$63.36M | +49.1% | |
| 5Y | -$63.36M | +49.1% | |
| All | -$63.36M | +49.1% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of TXG?
As of today, TXG quarterly EBIT is -$32.24M
What is TXG quarterly EBIT most recent change?
TXG quarterly EBIT was down -204.92% on September 30, 2025
What is 1-year change in TXG quarterly EBIT?
TXG quarterly EBIT is up +22.28% year-over-year
How far is TXG quarterly EBIT from its all-time high?
TXG quarterly EBIT is currently -2853.37% below its historical high of $1.17M set on September 30, 2018
How does TXG quarterly EBIT rank versus sector peers?
TXG quarterly EBIT is higher than 14.54% of companies in Healthcare sector
When is TXG next earnings release?
The next earnings release for TXG is on
TTM EBIT
-$140.82M$9.24M+6.16%
Summary
- Current Value
- As of today, TXG TTM EBIT is -$140.82M, up +6.16% on
- Historical Performance
- TXG TTM EBIT is up +20.99% year-over-year, and up +12.36% over the past 3 years
- All-Time High Comparison
- TXG TTM EBIT is currently -2202.93% below its historical high of -$6.12M set on
- 3-Year Low Comparison
- TXG TTM EBIT is +33.50% above its 3-year low of -$211.76M reached on
- Sector Comparison
- TXG TTM EBIT is higher than 12.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$140.82M | +6.2% | +21.0% | +12.4% | -54.9% | |
| Annual EBIT | -$177.70M | – | +28.6% | -236.2% | -535.7% | |
| Quarterly EBIT | -$32.24M | -204.9% | +22.3% | +19.4% | -32.8% | |
| Price | $19.29 | +59.8% | +21.9% | -48.9% | -87.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $641.81M | -0.4% | +1.9% | +27.4% | +145.1% | |
| TTM EPS | -$0.62 | +11.0% | +59.1% | +57.6% | +53.6% | |
| TTM EBITDA | -$98.54M | +9.8% | +26.1% | +23.5% | -30.5% | |
| TTM Net Income | -$76.32M | +9.8% | +58.2% | +54.4% | +43.2% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$140.82M | at high | |
| 3Y | -$140.82M | at high | |
| 5Y | -$39.44M | -257.1% | |
| All | -$6.12M | -2202.9% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$192.20M | N/A | +26.7% |
| 3Y | -$211.76M | +33.5% | |
| 5Y | -$211.76M | +33.5% | |
| All | -$211.76M | +33.5% |
TTM EBIT History
FAQ
What is the current TTM EBIT of TXG?
As of today, TXG TTM EBIT is -$140.82M
What is TXG TTM EBIT most recent change?
TXG TTM EBIT was up +6.16% on September 30, 2025
What is 1-year change in TXG TTM EBIT?
TXG TTM EBIT is up +20.99% year-over-year
How far is TXG TTM EBIT from its all-time high?
TXG TTM EBIT is currently -2202.93% below its historical high of -$6.12M set on March 1, 2017
How does TXG TTM EBIT rank versus sector peers?
TXG TTM EBIT is higher than 12.67% of companies in Healthcare sector
When is TXG next earnings release?
The next earnings release for TXG is on
EBIT Formula
EBIT = − −
Data Sources & References
- TXG Official Website www.10xgenomics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1770787/000162828025050332/0001628280-25-050332-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000177078725000013/0001770787-25-000013-index.htm
- TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
- TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg